204 related articles for article (PubMed ID: 16882281)
1. Intravenous immunoglobulin-associated cranial pachymeningitis.
Marie I; Hervé F; Lahaxe L; Robaday S; Gerardin E; Levesque H
J Intern Med; 2006 Aug; 260(2):164-7. PubMed ID: 16882281
[TBL] [Abstract][Full Text] [Related]
2. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature.
Mathy I; Gille M; Van Raemdonck F; Delbecq J; Depré A
Acta Neurol Belg; 1998 Dec; 98(4):347-51. PubMed ID: 9922823
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
[TBL] [Abstract][Full Text] [Related]
4. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B
Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279
[TBL] [Abstract][Full Text] [Related]
5. Cerebral sinus thrombosis in a patient with humoral immunodeficiency on intravenous immunoglobulin therapy: a case report.
Barada W; Muwakkit S; Hourani R; Bitar M; Mikati M
Neuropediatrics; 2008 Apr; 39(2):131-3. PubMed ID: 18671192
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic hypertrophic cranial pachymeningitis].
Beier D; Wilhelm H
Klin Monbl Augenheilkd; 2005 Sep; 222(9):740-5. PubMed ID: 16175486
[TBL] [Abstract][Full Text] [Related]
7. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
8. Aseptic meningitis induced by intravenous immunoglobulins in a child with acute Epstein-Barr virus infection and thrombocytopenia.
Vassalini P; Ajassa C; Di Ruscio V; Morace A; Vergari J; Tosato C; Savelloni G; Mastroianni CM
Infez Med; 2019 Jun; 27(2):194-197. PubMed ID: 31205046
[TBL] [Abstract][Full Text] [Related]
9. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
10. [A case of recurrent aseptic meningitis caused by high-dose intravenous gammaglobulin therapy for chronic inflammatory demyelinating polyneuropathy].
Kato T; Suzuki E; Sone M; Yoshida E; Hirayama M
Rinsho Shinkeigaku; 2001 Nov; 41(11):797-800. PubMed ID: 12080612
[TBL] [Abstract][Full Text] [Related]
11. Headache profile in patients with idiopathic hypertrophic cranial pachymeningitis.
Wang YJ; Fuh JL; Lirng JF; Lu SR; Wang SJ
Headache; 2004 Oct; 44(9):916-23. PubMed ID: 15447702
[TBL] [Abstract][Full Text] [Related]
12. Side-effects of intravenous immune globulins.
Duhem C; Dicato MA; Ries F
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
[TBL] [Abstract][Full Text] [Related]
13. Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center.
Bharath V; Eckert K; Kang M; Chin-Yee IH; Hsia CC
Transfusion; 2015 Nov; 55(11):2597-605. PubMed ID: 26095012
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic hypertrophic cranial pachymeningitis.
Sylaja PN; Cherian PJ; Das CK; Radhakrishnan VV; Radhakrishnan K
Neurol India; 2002 Mar; 50(1):53-9. PubMed ID: 11960152
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic hypertrophic cranial pachymeningitis: clinical-radiological-pathological correlation of bone involvement.
Jacobson DM; Anderson DR; Rupp GM; Warner JJ
J Neuroophthalmol; 1996 Dec; 16(4):264-8. PubMed ID: 8956162
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System.
Benadiba J; Robitaille N; Lambert G; Itaj NK; Pastore Y
Transfusion; 2015 Mar; 55(3):571-5. PubMed ID: 25355613
[TBL] [Abstract][Full Text] [Related]
17. [Adverse effects of administration of intravenous human immunoglobulins].
Bednarík J; Kadanka Z
Cas Lek Cesk; 1999 Nov; 138(21):647-9. PubMed ID: 10746020
[TBL] [Abstract][Full Text] [Related]
18. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
Chrissafidou A; Malek M; Musch E
Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic hypertrophic cranial pachymeningitis and dural sinus occlusion: two patients with long-term follow up.
Bhatia R; Tripathi M; Srivastava A; Garg A; Singh MB; Nanda A; Padma MV; Prasad K
J Clin Neurosci; 2009 Jul; 16(7):937-42. PubMed ID: 19375919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
